The company has developed a blood-based test to assess whether women are carriers of the antibodies that cause maternal autoantibody related-autism.

In addition to distributing Gradientech's QuickMIC system in the US and Canada, Hardy Diagnostics will become one of the firm's largest shareholders.

The firm received de novo marketing authorization for its combination antigen test, and the developers of subsequent tests will be able to seek 510(k) clearance.

Canadian life sciences firm Microbix Biosystems announced recently that it has received CE marking under the EU’s In Vitro Diagnostics Regulation for 11 of its diagnostic assay quality assessment ...

The Ireland-based firm said that the financing will support clinical trials of an HIV test and help the company to strengthen its product pipeline.

Last week, readers were most interested in a story about a new respiratory test launched by Roche leveraging a new PCR technology.

The firm executed contracts for 11 T2Dx instruments in the quarter and saw its sepsis test panel revenue increase 42 percent.

The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.

The company aims to streamline its own lab operations while also enabling distribution of its Alzheimer's tests to outside ...

The methods use heat to create bubbles that collect target particles. The bubbles leave behind concentrated deposits as they cool and shrink.

The firm raised $7.5 million in its financing round and plans to use the money for further development of its platform and regulatory milestones.

The BARDA funding will support studies to validate the Melbourne, Australia-headquartered firm's flagship FebriDx rapid host-response respiratory infection test in low-complexity settings and ...